PT3544972T - Ligandos opioides capa de heteroaril-fenoxi-benzamida - Google Patents

Ligandos opioides capa de heteroaril-fenoxi-benzamida

Info

Publication number
PT3544972T
PT3544972T PT178182812T PT17818281T PT3544972T PT 3544972 T PT3544972 T PT 3544972T PT 178182812 T PT178182812 T PT 178182812T PT 17818281 T PT17818281 T PT 17818281T PT 3544972 T PT3544972 T PT 3544972T
Authority
PT
Portugal
Prior art keywords
heteroarylphenoxy
benzamide
kappa opioid
opioid ligands
ligands
Prior art date
Application number
PT178182812T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PT3544972T publication Critical patent/PT3544972T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • C07D231/20One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT178182812T 2016-11-28 2017-11-27 Ligandos opioides capa de heteroaril-fenoxi-benzamida PT3544972T (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662426980P 2016-11-28 2016-11-28
US201762576435P 2017-10-24 2017-10-24
US201762585016P 2017-11-13 2017-11-13

Publications (1)

Publication Number Publication Date
PT3544972T true PT3544972T (pt) 2023-06-20

Family

ID=60782279

Family Applications (1)

Application Number Title Priority Date Filing Date
PT178182812T PT3544972T (pt) 2016-11-28 2017-11-27 Ligandos opioides capa de heteroaril-fenoxi-benzamida

Country Status (18)

Country Link
US (1) US10316021B2 (enExample)
EP (1) EP3544972B8 (enExample)
JP (1) JP7051853B2 (enExample)
CN (1) CN110234638B (enExample)
AU (1) AU2017365123B2 (enExample)
DK (1) DK3544972T3 (enExample)
ES (1) ES2947293T3 (enExample)
FI (1) FI3544972T3 (enExample)
HR (1) HRP20230518T1 (enExample)
HU (1) HUE061945T2 (enExample)
IL (1) IL266962B (enExample)
MX (1) MX389806B (enExample)
PH (1) PH12019501172A1 (enExample)
PL (1) PL3544972T3 (enExample)
PT (1) PT3544972T (enExample)
RS (1) RS64258B1 (enExample)
TW (1) TWI720272B (enExample)
WO (1) WO2018096510A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018154118A2 (en) * 2017-02-24 2018-08-30 Reinmueller Viktoria Novel aromatic compounds
AU2018223177B2 (en) * 2017-02-24 2024-05-02 Xeniopro GmbH Aromatic compounds which enhance notch signaling, for use in therapy
US11266627B1 (en) 2021-05-04 2022-03-08 Janssen Pharmaceuticals, Inc. Compositions and methods for the treatment of depression
CN111233768B (zh) * 2020-03-18 2021-08-03 徐州圣元化工有限公司 一种3-(二氟甲基)-1-甲基-1h-吡唑-4-羧酸乙酯的制备方法
KR20210151949A (ko) * 2020-04-05 2021-12-14 화이자 인코포레이티드 Covid-19의 치료를 위한 화합물 및 방법
US12161622B2 (en) 2021-05-04 2024-12-10 Janssen Pharmaceuticals, Inc. Compositions and methods for the treatment of depression
TW202345795A (zh) * 2022-03-07 2023-12-01 美商健生醫藥公司 純質形式之結晶型阿替卡普蘭
US11998524B2 (en) * 2022-03-07 2024-06-04 Janssen Pharmaceuticals, Inc. Forms of aticaprant
IL315415A (en) 2022-03-07 2024-11-01 Janssen Pharmaceuticals Inc The compositions containing eticarpant
AR130742A1 (es) * 2022-10-12 2025-01-15 Adama Makhteshim Ltd Proceso para la preparación de derivados de aminopiridazina

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
GB9518953D0 (en) 1995-09-15 1995-11-15 Pfizer Ltd Pharmaceutical formulations
WO2000035296A1 (en) 1996-11-27 2000-06-22 Wm. Wrigley Jr. Company Improved release of medicament active agents from a chewing gum coating
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
JP2000159747A (ja) 1998-09-21 2000-06-13 Takeda Chem Ind Ltd 新規チオ―ル誘導体、その製造法および用途
CA2344412A1 (en) 1998-09-21 2000-03-30 Takeda Chemical Industries, Ltd. Thiol compound, their production and use
IT1303737B1 (it) 1998-11-11 2001-02-23 Smithkline Beecham Spa Derivati fenilpiperidinici procedimento per la loro preparazione eloro uso come ligandi del recettore orl-1.
SI2208727T1 (sl) 2002-09-19 2012-11-30 Lilly Co Eli Diaril etri kot antagonisti opioidnega receptorja
US7365209B2 (en) 2003-02-11 2008-04-29 Pharmacopeia, Inc. Nitrogen heterocycle biaryls for osteoporosis and other diseases
BRPI0408108A (pt) 2003-03-07 2006-03-01 Lilly Co Eli composto, composição farmacêutica, métodos para bloquear em receptor mu, kappa, delta ou uma combinação de receptores dos mesmos em um mamìfero, para tratar ou prevenir obesidade e doenças relacionadas e para suprimir apetite, e, uso de um composto
EP2385040A1 (en) 2003-03-14 2011-11-09 ONO Pharmaceutical Co., Ltd. Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
RU2416608C2 (ru) 2004-08-06 2011-04-20 Оцука Фармасьютикал Ко., Лтд. Ароматическое соединение
CN101120055B (zh) 2005-02-18 2014-07-23 日本曹达株式会社 有机无机复合体
CA2644368A1 (en) 2006-03-10 2007-09-20 Ono Pharmaceutical Co., Ltd. Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
PT2001456E (pt) 2006-04-04 2010-03-03 Emodys Gmbh Utilização de composições contendo antagonistas dos receptores opióides kappa no tratamento de distúrbios dissociativos
WO2009094260A1 (en) 2008-01-22 2009-07-30 Eli Lilly And Company Kappa selective opioid receptor antagonist
WO2009102893A2 (en) 2008-02-14 2009-08-20 Amira Pharmaceuticals, Inc. CYCLIC DIARYL ETHER COMPOUNDS AS ANTAGONISTS OF PROSTAGLANDIN D2 receptors
CR11559A (es) 2008-03-25 2010-10-20 Lilly Co Eli Antagonista del receptor opioide selectivo kappa
US8048895B2 (en) 2008-04-18 2011-11-01 Research Triangle Institute Kappa opioid receptor ligands
EP2361248B1 (en) 2008-06-27 2018-09-19 Celgene CAR LLC Heteroaryl compounds and uses thereof
EP2379524A1 (en) 2008-12-18 2011-10-26 Boehringer Ingelheim International GmbH Serotonin 5-ht2b receptor inhibitors
HN2010001319A (es) 2009-01-26 2013-01-15 Lilly Co Eli Antagonista del receptor opioide selectivo kappa
WO2013059648A1 (en) 2011-10-21 2013-04-25 Neurotherapeutics Pharma, Inc. 2,3,5 trisubstituted aryl and heteroaryl amino derivatives, compositions, and methods of use
CN104684894A (zh) 2012-10-02 2015-06-03 默克专利股份有限公司 吡咯烷类
WO2015109080A1 (en) 2014-01-15 2015-07-23 Research Triangle Institute Kappa-opioid receptor selective opioid receptor antagonists
WO2016086149A1 (en) 2014-11-26 2016-06-02 University Of Kansas Antagonists of the kappa opioid receptor

Also Published As

Publication number Publication date
US20180148432A1 (en) 2018-05-31
US10316021B2 (en) 2019-06-11
JP2019535799A (ja) 2019-12-12
IL266962B (en) 2022-02-01
EP3544972A1 (en) 2019-10-02
WO2018096510A1 (en) 2018-05-31
ES2947293T3 (es) 2023-08-04
CA3045242A1 (en) 2018-05-31
EP3544972B8 (en) 2023-06-07
PL3544972T3 (pl) 2023-07-24
JP7051853B2 (ja) 2022-04-11
IL266962A (en) 2019-07-31
HRP20230518T1 (hr) 2023-08-04
PH12019501172A1 (en) 2019-12-11
NZ754862A (en) 2024-11-29
AU2017365123A1 (en) 2019-07-11
TW201831460A (zh) 2018-09-01
DK3544972T3 (da) 2023-05-30
EP3544972B1 (en) 2023-04-26
RS64258B1 (sr) 2023-07-31
AU2017365123B2 (en) 2022-02-17
FI3544972T3 (fi) 2023-06-02
MX389806B (es) 2025-03-20
CN110234638A (zh) 2019-09-13
CN110234638B (zh) 2022-10-21
MX2019006220A (es) 2019-10-07
HUE061945T2 (hu) 2023-09-28
TWI720272B (zh) 2021-03-01

Similar Documents

Publication Publication Date Title
PT3544972T (pt) Ligandos opioides capa de heteroaril-fenoxi-benzamida
HUE057538T2 (hu) Folyékony huzal
GB2528148B (en) Sustained-release buprenorphine solutions
GB2571867B (en) Wire strainers
GB201513850D0 (en) Coordinate positioning machine
GB2547540B (en) Strainers
GB201522437D0 (en) Tethered ligands
GB201514584D0 (en) A gasket
GB201610705D0 (en) A mattress
GB201406237D0 (en) A securable furniture arrangement
GB201509847D0 (en) Anti-dandruff agents
PT3389449T (pt) Um colchão
GB201615838D0 (en) Strainers
GB201509848D0 (en) Anti-dandruff Agents
HK40015851A (en) Heteroarylphenoxy benzamide kappa opioid ligands
GB201516302D0 (en) Shower head cover
GB201509849D0 (en) Anti-dandruff agents
ZA201802212B (en) A concealment cover
PL3551025T3 (pl) Zmywarka do naczyń
PL3515274T3 (pl) Zmywarka do naczyń
GB2548068B (en) A mattress
GB2543370B (en) A gasket arrangement
GB201620135D0 (en) Concept nine
AU5484P (en) Sundrench Fragaria xananassa
AU5613P (en) Florida127 Fragaria xananassa